Purchase Order 75N91026P00009
- Not listed
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute (NCI) to Bruker Biospin Corp, a manufacturer of scientific instruments. The $248,808.00 contract is for preventive and emergency maintenance and support services for one government-owned Bruker Avance Neo 700 nuclear magnetic resonance (NMR) spectrometer, in support of the NCI's Center for Cancer Research (CCR) Urologic Oncology...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,999 firm fixed price purchase order to Bruker Biospin Corp for a service agreement on a Bruker Avance NEO 700 NMR spectrometer. Performance will take place in Rockville, Maryland through May 2024. Bruker Corporation is the parent company of Bruker Biospin Corp, the prime contractor. No set-aside designation was used for this procurement to deliver maintenance and support services...
- This firm-fixed-price purchase order contract, awarded by the National Cancer Institute (NCI) to Bruker Biospin Corp, is valued at $369,168.00 and has an ultimate completion date of September 21, 2025. The contract is for the maintenance and preventive maintenance of a government-owned 700 MHz nuclear magnetic resonance (NMR) spectrometer console. This contract does not utilize any set-aside designations. Bruker Biospin Corp is a subsidiary of Bruker Scientific LLC, a prominent manufacturer of...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $198,198.00 firm fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, to provide preventive maintenance for a Bruker Avance NEO 700 nuclear magnetic resonance (NMR) spectrometer. This specialized equipment is utilized for clinical and research metabolomics applications, such as targeted stable isotope-resolved tracer studies in cultured cells...
- The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $158,684.80 firm fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for maintenance services on a government-owned Bruker preclinical magnetic resonance imaging (MRI) system used by the NCI's Center for Cancer Research (CCR). The purchase order will enable Bruker, the original equipment manufacturer, to provide regular...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $24,880.80 firm fixed price purchase order to Bruker Biospin Corp. for a service agreement for the Bruker AVANCE NEO 700 NMR spectrometer. The prime contractor, Bruker Biospin Corp., a subsidiary of Bruker Corporation, will provide maintenance and support services for the NMR spectrometer located in Rockville, Maryland over a period of three months from September 4, 2023 through December...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute (NCI) to Bruker Biospin Corp, a manufacturer of scientific instruments. The purpose is to acquire a full coverage maintenance service contract covering a 700 MHz nuclear magnetic resonance (NMR) spectrometer console, which is essential for research at the NCI's Laboratory of Biochemistry and Molecular Biology. The contract has a...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $17,015 purchase order to Bruker Biospin Corp. for maintenance services. Bruker Biospin Corp. will provide maintenance for scientific equipment located at the agency's facility in Bethesda, Maryland over a one-year base period of performance from August 2023 through August 2024. The contract is a firm fixed price agreement with Bruker Corporation, the parent company of Bruker Biospin...
- This is a firm-fixed price purchase order award from the Department of Health and Human Services National Institutes of Health National Cancer Institute to Bruker Biospin Corp, a manufacturer of scientific instruments, for preventive maintenance services on a government-owned 700 MHz nuclear magnetic resonance (NMR) spectrometer console. The potential value of the contract is $118,196.11. There was no set-aside designation for this contract. Bruker Biospin Corp provides specialized equipment,...
- The National Institutes of Health (NIH) National Cancer Institute (NCI) awarded a Firm Fixed Price Purchase Order to Bruker Biospin Corp, a manufacturer of scientific instruments, to upgrade the broadband parallel receiver system and RF coils for a government-owned Bruker BioSpec 3T MRI system. The $125,590.00 contract does not have a set-aside designation. Bruker Biospin Corp, a subsidiary of Bruker Corporation, has provided specialized equipment, maintenance, and support services to various...
The National Cancer Institute (NCI) awarded a firm fixed-price purchase order to Bruker Biospin Corp for preventative maintenance services on specialized scientific equipment, with a ceiling value of approximately $286K and an ultimate completion date of March 13, 2028. The contract covers maintenance for one Bruker AVANCE NEO 700 MHz Nuclear Magnetic Resonance (NMR) spectrometer with LabScape Complete integration and one Bruker preclinical BioSpec 3T Magnetic Resonance Imaging (MRI) system, both located at the contractor's facility in Billerica, Massachusetts. This procurement was awarded on a full and open competition basis with no small business set-aside designation, reflecting Bruker's competitive positioning as the manufacturer and sole qualified provider of specialized technical support for these proprietary systems. Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, is a premier supplier of advanced analytical instrumentation to federal research agencies. The company provides comprehensive maintenance and support services across the National Institutes of Health enterprise, including the NCI, spanning equipment procurement, preventive maintenance agreements, repair services, and technical upgrades. The contract supports the NCI's research operations by ensuring continued optimal performance and reliability of critical imaging and spectroscopy instrumentation essential for cancer research and diagnostic applications. This award represents continuation of Bruker's established federal contracting relationship with the NCI and broader NIH community, where the company maintains an extensive portfolio of maintenance and service agreements valued at multiple seven-figure amounts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $140.2k | 3/9/26 |